Print Page | Close Window

Analysts’ Estimates


Disclaimer: The analyst forecasts below are calculated by First Call based on the projections made by the analysts who cover Haemonetics Corporation. Please note that any opinions, estimates or forecasts regarding Haemonetics Corporation’s performance made by these analysts, including their average estimate numbers, are theirs alone and do not represent opinions, forecasts or predictions of Haemonetics Corporation or its management. Haemonetics Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Our actual earnings may differ materially from those below, and our earnings are subject to risks and uncertainties such as those described in Haemonetics Corporation’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.

Stock Information
Price (Prev Close):123.39Median Price Target:117.83
Price - 52 Week High123.88Diff from Prev Close:-5.56
Price - 52 Week Low80.24% Difference:-4.50%
Price Date (Latest):07/16/19  
Analyst Ratings
1-Strong Buy2
Mean Recommendation: 2.0

SellStrong Buy
Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualMar 224.574.614.534.572000.00
AnnualMar 213.643.863.353.71601-0.14
AnnualMar 202.943.002.902.947000.00
QuarterlyMar 200.820.860.780.837100.17
QuarterlyJun 190.630.670.600.647000.00
QuarterlySep 190.700.720.670.707000.00
QuarterlyDec 190.780.810.760.78701-0.18
Long Term Growth 12.0012.0012.0012.001000.00
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualMar 192.392.332.37
AnnualMar 181.871.870.13
AnnualMar 171.531.520.88
QuarterlyMar 190.610.5510.56
QuarterlyDec 180.630.596.52
QuarterlySep 180.560.543.43
QuarterlyJun 180.590.4242.17
Reference Information -
Last Actual (FY0):2.39
FY0 End Date:Mar 19
Hist (5 Yr) Growth %:9.14
Hist (5 Yr) Stability %:--
Data Provided by Thomson Reuters